To The Moon

In the ever-evolving landscape of biotechnology, ProKidney Corp. (PROK) stands out as a beacon of innovation, poised to redefine the treatment of chronic kidney disease (CKD) with its groundbreaking therapy, rilparencel. As of August 8, 2025, the stock has faced a recent dip, trading at $2.56 after a 10.94% decline on August 7. However, this presents a golden opportunity for astute investors to capitalize on a company with untapped potential that could revolutionize healthcare and deliver exponential returns. A Pioneering Approach to CKD Unlike traditional treatments that merely manage symptoms, ProKidney’s rilparencel offers a regenerative solution. This autologous cell therapy harnesses a patient’s own selected renal cells (SRC) to repair damaged kidney tissue, potentially delaying or ev

Post-Earnings Setup: Amazon (AMZN) Amazon’s Q2 earnings beat expectations on revenue and profits, but the stock slid 8% due to weaker profit guidance and underwhelming AWS growth. We have seen $Amazon.com(AMZN)$ recover and back above $220 level with a 0.37% gain on Thursday (07 Aug). In this article, I would like to share how an investor might approach it tactically for a post earnings trade setup. Tactical Plays After Earnings AI Infrastructure Convexity: Amazon raised its 2025 capex forecast to $118B, with a heavy tilt toward AI infrastructure. Investors could lean into this by tracking suppliers (e.g., data center REITs, chipmakers) or thematic ETFs exposed to cloud and AI buildouts. AWS vs. Azure/Google Cloud: AWS grew 18% YoY, but lagged riv

The reinstatement of reciprocal tariffs by the U.S. government has created significant volatility and uncertainty in global markets as of August 2025. The reinstatement of reciprocal tariffs, which was initially met with significant market volatility and fear, is now being viewed by some as a source of new opportunities. This shift in perspective is driven by a more detailed understanding of how these tariffs are being implemented and the resulting changes in the global trade landscape. Initially, markets reacted with panic to the broad, sweeping nature of the tariff announcements, which threatened to disrupt established global supply chains and potentially trigger a full-blown trade war. This led to sharp declines in stock markets, particularly in sectors like automotive and technology, a

$Yum(YUM)$ Yum! Brands, the global juggernaut behind Taco Bell, KFC, Pizza Hut, and The Habit Burger Grill, delivered a modest yet concerning Q2 2025 earnings report. With adjusted EPS of $1.44—a slight improvement from $1.35 a year earlier but falling short of the $1.46 analysts forecast—and revenues of $1.93 billion versus the $1.94 billion consensus, expectations were missed. The report comes as U.S. tariffs and rising ingredient costs continue to stretch margins, even as the company expands digitally and leans into Gen Z-focused innovations. Following the release, Yum! shares slid between 3% to 5% in pre‑market trading, underscoring investor caution amid mounting external challenges. Performance Overview and Market Feedback Over the second quar

$Opendoor Technologies Inc(OPEN)$ Open Door Technologies: Navigating Volatility Amid Market Challenges and Meme Stock Status As Open Door Technologies transforms from a promising real estate disruptor into a meme stock, investors face a complex landscape marked by rapid share price swings, evolving business strategy, and ongoing headwinds in the U.S. housing market. This analysis reviews the company’s latest quarterly results, updated valuation, and offers a measured outlook for investors weighing risk and opportunity. Performance Overview and Market Feedback Open Door’s second-quarter earnings reflected both progress and ongoing challenges. The company generated $1.6 billion in revenue—a 4% increase year-over-year and a robust 36% sequential gain